Rongchang biological startup counseling plans to make a secondary listing of A shares. Last year, the listing of Hong Kong shares created the world's largest biomedical IPO at that time.

IPO早知道 · Mar 9, 2021 08:58

【Rongchang organismLast year, Hong Kong shares listed as the world's largest biomedical IPO] Rongchang Biopharmaceutical (Yantai) Co., Ltd. signed a listing guidance agreement with Huatai United Securities on March 2, and recently put A shares on record in Shandong Securities Regulatory Bureau, intending to list A shares. This means that Rongchang, which has just been listed in Hong Kong for four months and created the world's largest biomedical IPO in 2020, has officially launched a secondary listing of A shares. (IPO knew)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

荣昌生物启动辅导拟A股二次上市，去年港股上市曾创当年全球最大生物医药IPO

Rongchang biological startup counseling plans to make a secondary listing of A shares. Last year, the listing of Hong Kong shares created the world's largest biomedical IPO at that time.

Risk Disclaimer

Statement